ASRT - Assertio Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ASRT is currently covered by 2 analysts with an average price target of $8.64. This is a potential upside of $7.9 (1067.57%) from yesterday's end of day stock price of $0.74.

Assertio Therapeutics's activity chart (see below) currently has 55 price targets and 40 ratings on display. The stock rating distribution of ASRT is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 54.61% with an average time for these price targets to be met of 118.1 days.

Highest price target for ASRT is $8, Lowest price target is $1.

Most recent stock forecast was given by THOMAS FLATEN from LAKE STREET on 04-Jan-2024. First documented stock forecast 16-Jan-2015.

Currently out of the existing stock ratings of ASRT, 8 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$4

$3 (300.00%)

$4

1 years 11 months 11 days ago
(04-Jan-2024)

1/5 (20%)

$3.1 (344.44%)

184

Buy

$4

$3 (300.00%)

$6

2 years 1 months 12 days ago
(03-Nov-2023)

1/5 (20%)

$1.66 (70.94%)

289

Hold

$16

$14.89 (1341.44%)

$52

6 years 4 months 7 days ago
(08-Aug-2019)

1/5 (20%)

$4.76 (42.35%)

59

Hold

$12

$9.09 (312.37%)

$28

6 years 6 months 29 days ago
(16-May-2019)

9/12 (75%)

$5.34 (9.39%)

50

Buy

$40

7 years 3 months 16 days ago
(29-Aug-2018)

1/9 (11.11%)

$6.64 (19.90%)

120

Show more analysts

Please expand the browser size to see the chart

What is ASRT (Assertio Therapeutics) average time for price targets to be met?

On average it took 118.1 days on average for the stock forecasts to be realized with a an average price target met ratio 54.61

Which analyst has the current highest performing score on ASRT (Assertio Therapeutics) with a proven track record?

AMI FADIA

Which analyst has the most public recommendations on ASRT (Assertio Therapeutics)?

Ami Fadia works at NEEDHAM and has 7 price targets and 4 ratings on ASRT

Which analyst is the currently most bullish on ASRT (Assertio Therapeutics)?

Scott Henry with highest potential upside - $112.89

Which analyst is the currently most reserved on ASRT (Assertio Therapeutics)?

Ken Trbovich with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?